VATICAN CITY, May 10, 2021 (LifeSiteNews) — The Holy See announced the granting of a Pontifical Award to the CEO of a pharmaceutical company that makes abortion-tainted experimental coronavirus vaccines at a Vatican-hosted health conference the company helped fund.
Stéphane Bancel, the CEO of Moderna, was given a Pontifical Hero Award in recognition of his success in convincing the company to focus its energies on developing a vaccine for the COVID-19 coronavirus.
In May 6’s online broadcast of “Fifth International Vatican [Health] Conference, Bancel was also the subject of a soft interview or “conversation” with Dr. Max Gomez, a medical journalist who is also on the Board of Directors for the co-hosting CURA foundation. Bancel told Gomez about mRNA technology and revealed that Moderna has already produced a “booster” to deal with new variants of the COVID-19 vaccine as they arise.
Meanwhile, Moderna is listed as a “Key Gold” supporter or grantor of the Vatican conference.
The experimental coronavirus mRNA injections, including those produced by Moderna, have been linked to eye disorders including blindness, death, mild to severe injuries, reproductive disfunction, and allergic reactions.
The Pontifical Council for Culture, headed by Cardinal Gianfranco Ravasi, and the CURA health foundation are currently presenting their online conference, which this year has the title “Exploring the Mind, Body and Soul.” The pre-recorded online conversations that make up the conference are being presented in a three-day format, over a three-day period, May 6 to May 8.
The May 6 presentations involved conversations with, and soft interviews of, executives from other pharmaceutical and biotechnology companies: Dr. Albert Bourla, the Chairman and CEO of Pfizer, which produces abortion pills; Dr. Robert J. Hariri, the Chairman and CEO of Celularity and Dr. Andrew Pecora, Celularity’s Director; Dr. Henry Ji, the Chairman, President and CEO of Sorrento Therapeutics; Stéphane Bancel, the CEO of Moderna; and Dr. Samarth Kulkarni, CEO of CRISPR Therapeutics.
Meanwhile, pharmaceutical and biotechnology companies known to have funded the event include Celularity, Sorrento Therapeutics, Moderna, CRISPR Therapeutics, Amicus Therapeutics, and United Therapeutics.
Another interesting grantor and participant in the Vatican conference is the Church of Jesus Christ of Latter-day Saints (“Key Copper”).